JeanChristophe Rue - Dialogue Health Director Relations
Insider
JeanChristophe Rue is Director Relations of Dialogue Health Technologies
| Web | https://dialogue.co |
Dialogue Health Management Efficiency
The company has return on total asset (ROA) of (0.1352) % which means that it has lost $0.1352 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.251) %, meaning that it generated substantial loss on money invested by shareholders. Dialogue Health's management efficiency ratios could be used to measure how well Dialogue Health manages its routine affairs as well as how well it operates its assets and liabilities.Dialogue Health Technologies has accumulated 1.07 M in total debt with debt to equity ratio (D/E) of 0.03, which may suggest the company is not taking enough advantage from borrowing. Dialogue Health Tech has a current ratio of 4.02, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Dialogue Health until it has trouble settling it off, either with new capital or with free cash flow. So, Dialogue Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Dialogue Health Tech sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Dialogue to invest in growth at high rates of return. When we think about Dialogue Health's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 8 records | INSIDER Age | ||
| Ross MD | biote Corp | 52 | |
| Cary Paulette | biote Corp | 62 | |
| Teresa Weber | biote Corp | 72 | |
| Joe Butler | biote Corp | 62 | |
| Samar Kamdar | biote Corp | 45 | |
| Jade Beutler | biote Corp | 62 | |
| Jennifer Schimmel | biote Corp | 51 | |
| Richard Key | biote Corp | 54 | |
Management Performance
| Return On Equity | -0.25 | |||
| Return On Asset | -0.14 |
Dialogue Health Tech Leadership Team
Elected by the shareholders, the Dialogue Health's board of directors comprises two types of representatives: Dialogue Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Dialogue. The board's role is to monitor Dialogue Health's management team and ensure that shareholders' interests are well served. Dialogue Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Dialogue Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Cherif Habib, CEO CoFounder | ||
| Navaid Mansuri, Chief Officer | ||
| JeanMarc Ayas, Director Relations | ||
| Lilian Lau, VP Marketing | ||
| Randy Wetmore, VP Sales | ||
| JeanNicolas Guillemette, Chief Officer | ||
| JeanChristophe Rue, Director Relations | ||
| Jennifer Buckley, VicePres Commercial | ||
| Alexis Smirnov, CoFounder CTO | ||
| Nathalie Delisle, Corp Counsel |
Dialogue Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Dialogue Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.25 | |||
| Return On Asset | -0.14 | |||
| Profit Margin | (0.33) % | |||
| Operating Margin | (0.33) % | |||
| Current Valuation | 78.04 M | |||
| Shares Outstanding | 66.34 M | |||
| Shares Owned By Insiders | 14.98 % | |||
| Shares Owned By Institutions | 47.40 % | |||
| Price To Earning | 6.90 X | |||
| Price To Book | 1.84 X |
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in Dialogue Pink Sheet
If you are still planning to invest in Dialogue Health Tech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Dialogue Health's history and understand the potential risks before investing.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |